Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Promising Results for CAR-T Cell therapy for Follicular Lymphoma | Matthew Frank, MD, PhD | #ASH24
Playlist: ASH 2024

Promising Results for CAR-T Cell therapy for Follicular Lymphoma | Matthew Frank, MD, PhD | #ASH24

Video details & playlist
Thumbnail for Allogeneic & Autologous Stem Cell Transplant for Follicular Lymphoma | Yasmina Serroukh, MD | #ASH24
Playlist: ASH 2024

Allogeneic & Autologous Stem Cell Transplant for Follicular Lymphoma | Yasmina Serroukh, MD | #ASH24

Video details & playlist
Thumbnail for Odronextamab as First-Line Therapy in Follicular Lymphoma | Rueme Birhiray, MD | #ASH24
Playlist: ASH 2024

Odronextamab as First-Line Therapy in Follicular Lymphoma | Rueme Birhiray, MD | #ASH24

Video details & playlist
Thumbnail for CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24
Playlist: ASH 2024

CAR-T Cell Therapy for Transformed Follicular Lymphoma | Matthew Cortese, MD | #ASH24

Video details & playlist
Thumbnail for Rituximab for Low Tumor Burden Follicular Lymphoma | Noriko Fukuhara MD, PhD | #ASH24
Playlist: ASH 2024

Rituximab for Low Tumor Burden Follicular Lymphoma | Noriko Fukuhara MD, PhD | #ASH24

Video details & playlist
Thumbnail for Positive Loncastuximab & Rituximab Results in R/R Follicular Lymphoma | Juan Alderuccio, MD | #ASH24
Playlist: ASH 2024

Positive Loncastuximab & Rituximab Results in R/R Follicular Lymphoma | Juan Alderuccio, MD | #ASH24

Video details & playlist
Avatar
ChioOsuna
Follicular Lymphoma Discussion • December 13, 2024
You Made This ASH Research Possible
AI-generated title
At ASH this year, researchers presented groundbreaking data from collaborative studies with HealthTree. Your participation in Cure Hub made this possible, showcasing the power of real-world data in driving meaningful advancements in care and research. Thank you for being an essential part of this progress! #ASH24 #HealthTree #PatientAdvocacy #InnovationThatSavesLives #ASHMeeting #Hematology #BloodCancer #MedicalResearch #CancerCare #ASH2024